Publications by authors named "Kerry Townsend"

Claim this Profile
A
Association of Expanded Medicaid Coverage With Hospital Length of Stay After Injury.
Jeremy L Holzmacher, Kerry Townsend, Caleb Seavey, Stephanie Gannon, Mary Schroeder

JAMA Surg· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
Kerry Townsend, Eric G Meissner, Sreetha Sidharthan, Maureen Sampson, Alan T Remaley

AIDS Res Hum Retroviruses· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study.
Tess Petersen, Kerry Townsend, Lori A Gordon, Sreetha Sidharthan, Rachel Silk

Hepatol Int· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir.
Kerry Townsend, Tess Petersen, Lori A Gordon, Anita Kohli, Amy Nelson

AIDS· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug Interactions in Patients Co-infected With HCV and HIV--Reply.
Anu Osinusi, Kerry Townsend, Shyam Kottilil

JAMA· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.
Anu Osinusi, Kerry Townsend, Anita Kohli, Amy Nelson, Cassie Seamon

JAMA· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.
Anita Kohli, Anuoluwapo Osinusi, Zayani Sims, Amy Nelson, Eric G Meissner, Kerry Townsend

Lancet· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study.
Anu Osinusi, Anita Kohli, Miriam M Marti, Amy Nelson, Xiaozhen Zhang, Kerry Townsend

Ann Intern Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C.
Shivakumar Narayanan, Kerry Townsend, Thomas Macharia, Adrian Majid, Amy Nelson

Hepatol Int· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients.
Madeline Odigie, Anu Osinusi, Lisa Barrett, Kerry Townsend, Honghui Wang

AIDS Res Hum Retroviruses· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short communication: serum-based assay accurately detects single nucleotide polymorphisms of IL28B and SOCS3 in HIV/hepatitis C virus-coinfected subjects.
Ashton Shaffer, Jon J Hubbard, Kerry Townsend, Shyam Kottilil, Michael A Polis

AIDS Res Hum Retroviruses· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contact angle, WAXS, and SAXS analysis of poly(beta-hydroxybutyrate) and poly(ethylene glycol) block copolymers obtained via Azotobacter vinelandii UWD.
Kerry J Townsend, Karsten Busse, Joerg Kressler, Carmen Scholz

Biotechnol Prog· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis